TRUST CO OF VERMONT - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
TRUST CO OF VERMONT ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,640
+5.9%
2000.0%0.00%
Q2 2023$7,214
-5.6%
2000.0%0.00%
-100.0%
Q1 2023$7,638
-32.9%
2000.0%0.00%0.0%
Q4 2022$11,380
+42.2%
2000.0%0.00%0.0%
Q3 2022$8,000
-11.1%
2000.0%0.00%0.0%
Q2 2022$9,000
+12.5%
2000.0%0.00%0.0%
Q4 2021$8,000
-11.1%
2000.0%0.00%0.0%
Q2 2021$9,000
+12.5%
2000.0%0.00%0.0%
Q1 2021$8,000
-11.1%
2000.0%0.00%0.0%
Q4 2020$9,000
+80.0%
2000.0%0.00%
Q3 2020$5,0000.0%2000.0%0.00%
Q2 2020$5,000
+25.0%
2000.0%0.00%
Q1 2020$4,0000.0%2000.0%0.00%
Q4 2019$4,000
+33.3%
2000.0%0.00%
Q3 2019$3,0000.0%2000.0%0.00%
Q2 2019$3,0000.0%2000.0%0.00%
Q1 2019$3,0000.0%2000.0%0.00%
Q4 2018$3,000
-25.0%
2000.0%0.00%
Q3 2018$4,000
+33.3%
2000.0%0.00%
Q2 2018$3,000
-25.0%
2000.0%0.00%
Q1 2018$4,0000.0%2000.0%0.00%
Q4 2017$4,0002000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
Bellevue Group AG 318,000$3,841,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders